Organigram Is A Small-Cap Bargain
Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio. See why I rate OGI ...
Occidental Petroleum Hit Its $4.5 Billion Debt Reduction Target 7 Months Early. That's Paying Big Dividends for Investors.
Occidental Petroleum (NYSE: OXY) unveiled a very bold move at the end of 2023. The oil producer agreed to buy CrownRock for $12 billion to bulk up its position in the oil-rich Permian Basin. A notable ...
Innoviva: Underappreciated Strength In Hospital Therapeutics
Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...